Last update 23 Jan 2025
Alsonex Pty Ltd.

Alsonex Pty Ltd.

Private Company|
2014|
Australia
|
www.alsonex.com.au

Overview

Tags

Nervous System Diseases
Congenital Disorders
Other Diseases
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Synthetic peptide1
Top 5 TargetCount
C5AR1(C5a anaphylatoxin chemotactic receptor)1

Related

1
Drugs associated with Alsonex Pty Ltd.
ALS-205
Target
C5AR1
Mechanism
C5AR1 antagonists
Active Org.
Alsonex Pty Ltd.Alsonex Pty Ltd. [+1]
Originator Org.
The University of QueenslandThe University of Queensland
Active Indication
Huntington Disease [+1]
Inactive Indication
Amyotrophic Lateral Sclerosis [+2]
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Alsonex Pty Ltd.
ACTRN12622000927729
/ CompletedPhase 1
An open-label, phase 1b study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of two doses of PMX205 in patients with amyotrophic lateral sclerosis
ACTRN12619001639112
/ CompletedPhase 1
A randomised, double-blind, placebo-controlled, phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of PMX205 in healthy volunteers.
100 Clinical Results associated with Alsonex Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Alsonex Pty Ltd.
Login to view more data
100 Deals associated with Alsonex Pty Ltd.
Login to view more data
100 Translational Medicine associated with Alsonex Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ALS-205
 ( C5AR1 )		Huntington Disease
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free